Abbott Laboratories
General ticker "ABT" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $200.2B
Abbott Laboratories follows the US Stock Market performance with the rate: 16.9%.
Estimated limits based on current volatility of 0.8%: low 112.96$, high 114.74$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends: last record date 2024-10-15, amount 0.55$ (Y1.92%)
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [98.96$, 138.37$]
- 2024-12-30 to 2025-12-30 estimated range: [117.15$, 159.28$]
Financial Metrics affecting the ABT estimates:
- Positive: Non-GAAP EPS, $ of 4.44 > 2.29
- Positive: 9.05 < Operating profit margin, % of 16.15
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Positive: -3.48 < Investing cash flow per share, $ of -1.81
- Negative: Industry earnings per price (median), % of -6.44 <= 1.31
- Positive: Return on assets ratio (scaled to [-100,100]) of 7.25 > 7.10
- Negative: Inventory ratio change, % of 1.69 > 1.08
- Positive: 2.35 < Operating cash flow per share per price, % of 3.95
Short-term ABT quotes
Long-term ABT plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $43,075.00MM | $43,653.00MM | $40,109.00MM |
| Operating Expenses | $34,650.00MM | $35,291.00MM | $33,631.00MM |
| Operating Income | $8,425.00MM | $8,362.00MM | $6,478.00MM |
| Non-Operating Income | $-214.00MM | $-56.00MM | $186.00MM |
| Interest Expense | $490.00MM | $375.00MM | $637.00MM |
| R&D Expense | $2,742.00MM | $2,888.00MM | $2,741.00MM |
| Income(Loss) | $8,211.00MM | $8,306.00MM | $6,664.00MM |
| Taxes | $1,140.00MM | $1,373.00MM | $941.00MM |
| Profit(Loss) | $7,071.00MM | $6,933.00MM | $5,723.00MM |
| Stockholders Equity | $35,802.00MM | $36,686.00MM | $38,603.00MM |
| Inventory | $5,157.00MM | $6,173.00MM | $6,570.00MM |
| Assets | $75,196.00MM | $74,438.00MM | $73,214.00MM |
| Operating Cash Flow | $10,533.00MM | $9,581.00MM | $7,261.00MM |
| Capital expenditure | $1,885.00MM | $1,777.00MM | $2,202.00MM |
| Investing Cash Flow | $-2,008.00MM | $-1,740.00MM | $-3,133.00MM |
| Financing Cash Flow | $-5,494.00MM | $-7,636.00MM | $-7,091.00MM |
| Earnings Per Share* | $3.97 | $3.94 | $3.30 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.